San Francisco, 03 January , Heart
Attack Diagnostics Market Analysis by Test type (Electrocardiogram, Blood Tests
(Troponin, CK-MB), Echocardiogram), by Region (U.S., Canada, UK, Germany,
China, India, Brazil, Mexico, South Africa, Middle East), and Segment Forecasts
to 2024.
The heart attack diagnostics market is
expected to reach USD 15.4 billion by 2024, according to a new report by Grand
View Research, Inc. The heart attack diagnostics market is anticipated to
witness a lucrative growth during the forecast period from2016 to 2024. From
2001 to 2011, age-standardized, heart attack incidence rates have significantly
decreased worldwide. However, the overall risk factors and the disease burden
remains large, thereby rendering the heart attack diagnostic sectors a
profitable growth prospect. This growth is attributed to a majority of factors,
such as high prevalence of coronary heart diseases, increased tobacco smoking,
and obesity, enhanced adoption of unhealthy diet is resulting in a high
cholesterol incidence in individuals, particularly in the rising geriatric population.
However, the low Medicare reimbursement provided for the mobile cardiac
outpatient telemetry electrocardiogram (ECG) and the progressively declining
heart attack incidence rates are expected to hamper the market growth.
The heart attack diagnostics market has been classified
by product into electrocardiogram, which measures the electrical activity of
the heart; echocardiogram, a form of ultrasound test that provides images of
the heart; blood tests that measure the expression of certain proteins in
excess, such as troponin levels, and cardiac enzymes; and other diagnostic
products. The ECG segment is expected to witness a significant growth rate in
developing countries, owing to the technological advances coupled with
increasing applications of ECG. Although, the increasing demand for cost
effective, rapid blood tests such as troponin and Creatine Kinase MB Isoenzyme
(CK-MB) is likely to acquire major market share in the near future. The key
countries landscape included in the report are U.S., Canada, Germany, UK,
China, India, Brazil, Mexico, South Africa, and Middle East. The Asia Pacific region is anticipated to
be the fastest growing region during the forecast period. On the other hand,
North America is estimated to dominate the global heart attack diagnostics
market.
Access Full Research
Report On Heart Attack Diagnostics Analysis:
Further key findings from the study suggest:
·
North America is estimated to
dominate the global heart attack diagnostics market. The increasing awareness
about heart attacks, its causative and risk factors, and enhanced uptake and
acceptance of technologically advanced diagnostics is expected to contribute to
the market growth.
·
The Asia Pacific region is
expected to be the fastest growing region during the forecast period. to The
reason being the considerably large burden of heart diseases in certain
developing regions, such as in India, where 2.4 million people die annually due
to heart diseases. As a result of the soaring incidences of heart diseases, an
urgent requirement to undertake awareness measures and incorporate advanced
diagnostics is expected to fuel the market growth.
·
The troponin blood test type is
the largest grossing segment and is expected to capture the largest share in
2015, especially in developing countries including Brazil, China, and India.
Its applications as a cardiac monitoring device and its indispensable use as a
heart attack diagnostic tool will be a contributing factor supporting the
market growth. The industry comprises of several local as well as global
players. Some of the major players of this industry include Siemens Healthcare
GmbH, Schiller AG, GE Healthcare, and Hitachi Medical Systems.
Browse More Reports Of This
Category By Grand View Research At: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the heart attack
diagnostics market on the basis of product and region:
Heart Attack Diagnostics Test
Type Outlook (Revenue, USD Million, 2013 - 2024)
·
Electrocardiogram (ECG)
·
Blood tests
o
Troponin
o
CK-MB
o
Others
·
Others
Heart Attack Diagnostics Regional
Outlook (Revenue, USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
Middle East
o
South Africa
Access Full Press Release of this Report:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
